Wird geladen...

Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy

BACKGROUND: Ovarian malignancies are often diagnosed in advanced stage and at the same time resistance to treatment, both intrinsic and developed during treatment, is sometimes observed. These facts underscore the need for new markers of ovarian cancer risk, as well as markers of treatment effective...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Exp Clin Cancer Res
Hauptverfasser: Tecza, Karolina, Pamula-Pilat, Jolanta, Kolosza, Zofia, Radlak, Natalia, Grzybowska, Ewa
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320471/
https://ncbi.nlm.nih.gov/pubmed/25591549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0124-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!